Fresenius medical care ag FMS.US Overview Analysis
)FMS AI Analysis Overview
Keys for Bullish View
- Value≥4
- Dividend≥2
Analysis Conclusion
The stock has achieved the highest rating for both its value and dividend scores. It's a prime choice for long-term accumulation. For optimal entry, check our trend or swing trading rating.
FMS Current Performance
-0.60%
Fresenius medical care ag
1.31%
Avg of Sector
0.58%
S&P500
Top 10 High Relevance to FMS
- DVA Davita incValue 3Trend 1Swing Trading 4Whale Interest 2Dividend 1See more
FMS Profile
Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD) and offers other extracorporeal therapies, as well as other healthcare services. It has two operating segments such as care delivery segment which consolidates the global health care services business and care enablement segment includes research and development (R&D), manufacturing, supply chain, and commercial operations. It develops and manufactures health care products, which includes dialysis and non-dialysis products. Such as hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. It owns, operates, or manages dialysis clinics sells products to other dialysis providers.